Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
about
HLA-dependent tumour development: a role for tumour associate macrophages?Immunogenicity of Human Mesenchymal Stem Cells in HLA-Class I-Restricted T-Cell Responses Against Viral or Tumor-Associated AntigensPlasma levels of soluble HLA-E and HLA-F at diagnosis may predict overall survival of neuroblastoma patientsTolerogenic function of dimeric forms of HLA-G recombinant proteins: a comparative study in vivoAugmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions.Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins.Immunogenicity of allogeneic mesenchymal stem cells transplanted via different routes in diabetic ratsSoluble HLA-G: Are they clinically relevant?Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric study.Immunology and immunotherapy of neuroblastomaMechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.Non-classical major histocompatibility complex proteins as determinants of tumour immunosurveillance.Soluble HLA-G and HLA-E Levels in Bone Marrow Plasma Samples Are Related to Disease Stage in Neuroblastoma Patients.Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significanceClinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer.Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma.Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.Molecular pathways and targets in cancer-related inflammation.Immunogenicity of insulin-producing cells derived from human umbilical cord mesenchymal stem cells.Immunosuppressive microenvironment in neuroblastoma.Tumor-associated macrophages: from mechanisms to therapy.New insights into HLA-G mediated tolerance.Evaluation of bone marrow as a metastatic site of human neuroblastoma.The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases.More than the genes, the tumor microenvironment in neuroblastoma.Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients.Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells.Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G.HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: the influence of the tumor microenvironment.Highlights of the third International Conference on Immunotherapy in Pediatric Oncology.IL-10 and ARG-1 concentrations in bone marrow and peripheral blood of metastatic neuroblastoma patients do not associate with clinical outcome.MYCN: from oncoprotein to tumor-associated antigenSoluble HLA-G modulates miRNA-210 and miRNA-451 expression in activated CD4+ T lymphocytes.Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma.Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites.Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.Human leukocyte antigen-G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment.T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-G.
P2860
Q27022124-C29CB731-4CEE-4EB4-B7F8-F765250D652CQ27489354-3B436E4E-4BF9-4EA4-B920-612DC76B447CQ28304289-33879F8B-4324-49B5-BFCE-1F8CEF70B23CQ28742634-EF0E0E97-4245-42BA-B879-D3C4E108F873Q33315601-6BD4EAE5-35AB-4616-A2F3-4EDDA25E968BQ34130792-E294F1B5-DC98-4364-9A74-3C23D6495921Q35833631-08F386DB-8441-42BD-AD26-FCB479CB997CQ36384011-A089D1EC-2A9D-4CFD-AAF4-989D649AB459Q36545749-B375C0B8-C6C8-4712-85CA-9801A90B78E0Q36582874-6BC94438-1F13-4992-B352-34AC2600D495Q36856798-44B13641-07BE-42A0-A949-18F6FBB55E6DQ36883879-B5248355-3EFE-4E70-8EA5-7A50036574B8Q36986947-665253F0-F9FD-48E4-B0A2-29A2850BA8DAQ37215353-0D10BE4A-2810-438F-9DC5-A63B0AEA11EAQ37242917-E94D2351-DDA1-4006-91EC-F2467FF535F3Q37287152-2D148D39-A60B-43C9-B435-CB47B6F6C700Q37293938-E18D74D3-6A3C-45A2-B286-AEAAD744556EQ37294991-D9E15D60-46D3-4248-B9CF-FF07690F01A0Q37406706-56D5AA09-429B-4FE9-8881-148C15FED984Q37729131-EF3185FE-5841-4130-B959-DB2113B5FD89Q37734573-FDA10D4F-CCA8-4598-8766-35A862F2E3F7Q38117379-13146102-F98C-430E-90C9-81CE9AFC04FDQ38230880-AF73C247-C57B-4344-9E72-252CDAC8790BQ38240763-A22C29FB-12C4-4E25-8266-BABECBFB4A01Q38260230-33BE4A50-32C5-4824-9249-9AA7C6EBBFABQ38362617-49CF5D54-AB4B-4CCF-A359-FE8AD4A5F8A7Q38644731-9B7A0974-4CC6-40BD-97D3-A1C7379682F8Q38886708-2C71AE32-3620-4A60-8B56-4D98CE6C5C75Q38889621-910274CB-D1BE-474C-AE25-7D75DADC0704Q39135703-59EF27DC-CD53-4900-8FC8-6FE47EF00DBCQ39334954-B0A145A5-420D-4875-AD18-8716920B8C43Q39403785-503B61FB-E442-43AF-B1A6-7FBB551F609EQ40190430-35BD5B96-2591-4B75-9D3F-F65A416310B9Q41111508-908FE4BE-8954-4113-BB43-900C4C1C1336Q41510335-CFBE9FA0-78DC-4560-AAED-E09DE7CAC0ADQ45061505-ADD40FD4-B7EE-4639-92A9-649AA0C166E1Q47410788-5D6AA5CA-F477-4C0D-8A32-C60802388526Q48199480-1E10CEC6-D8F4-4FC8-AA83-C78BCEC75407Q49335253-6626C3E2-92C1-467E-ADD4-F27A75B0AAC3Q49787397-1D5ABED5-F817-42D4-979C-036334233EB0
P2860
Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Human neuroblastoma cells trig ...... ulating soluble HLA-G release.
@en
type
label
Human neuroblastoma cells trig ...... ulating soluble HLA-G release.
@en
prefLabel
Human neuroblastoma cells trig ...... ulating soluble HLA-G release.
@en
P2093
P1433
P1476
Human neuroblastoma cells trig ...... ulating soluble HLA-G release.
@en
P2093
Barbara Galleni
Ignazia Prigione
Isabella Levreri
Paola Bocca
Soldano Ferrone
Vito Pistoia
P304
P356
10.1158/0008-5472.CAN-06-4588
P407
P577
2007-07-01T00:00:00Z